Suvretta Capital Management, LLC Infla Rx N.V. Transaction History
Suvretta Capital Management, LLC
- $2.33 Billion
- Q1 2024
A detailed history of Suvretta Capital Management, LLC transactions in Infla Rx N.V. stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 5,733,910 shares of IFRX stock, worth $9.98 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
5,733,910
Previous 5,733,910
-0.0%
Holding current value
$9.98 Million
Previous $9.35 Million
5.52%
% of portfolio
0.38%
Previous 0.49%
Shares
3 transactions
Others Institutions Holding IFRX
# of Institutions
40Shares Held
13.8MCall Options Held
12.9KPut Options Held
0-
Eversept Partners, LP New York, NY1.31MShares$2.27 Million0.15% of portfolio
-
Citigroup Inc1.2MShares$2.09 Million0.0% of portfolio
-
Morgan Stanley New York, NY979KShares$1.7 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY870KShares$1.51 Million0.11% of portfolio
-
Tang Capital Management LLC San Diego, CA769KShares$1.34 Million0.14% of portfolio
About InflaRx N.V.
- Ticker IFRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,203,800
- Market Cap $76.9M
- Description
- InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...